FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Sunday

 

Using chemo to treat MS shows 'remarkable' promise



















In this file photo, a nurse places a patient's chemotherapy medication on an intravenous stand. (AP Photo/Matt Rourke, File)

Chemotherapy is well-known as a cancer treatment, but it could also be a big part of the cure for many with multiple sclerosis, the Guardian reports.

Over the past few years, about 20 MS patients in the US, England, Brazil, and Sweden have been given a new treatment—known as autologous haematopoietic stem cell transplant, or HSCT—with what one researcher calls "remarkable results." As the BBC explains, MS "causes the immune system to attack the lining of nerves in the brain and spinal cord." HSCT uses chemotherapy to tear down a patient's immune system before regrowing it using their own stem cells, the Guardian reports.

“The immune system is being reset or rebooted back to a time point before it caused MS," hematologist John Snowden says. Steven Storey, one of the patients who's received the new treatment, tells the BBC he "went from running marathons" to being wheelchair-bound and unable to "hold a spoon and feed myself" within a year of his MS diagnosis. Four months after the treatment, he can stand without help. "It's been incredible," Storey says. "I was in a dire place, but now I can swim and cycle, and I am determined to walk." According to the Guardian, HSCT can be used to treat the most common type of MS, known as relapsing remitting multiple sclerosis, although researchers stress that more study is needed and it may not be suitable for all patients. HSCT has a one-time cost for patients of a little more than $40,000—comparable to a full year of traditional MS treatment, the BBC reports. (Actress Jamie-Lynn Sigler just revealed she's had MS since starring in The Sopranos.)

Story Source: The above story is based on materials provided by FOXNEWS
Note: Materials may be edited for content and length


Go to Newer News Go to Older News